Switching away from sulfonylureas in type 2 diabetes safety care
Part of Hormones & metabolism clinical trials.
This trial helps patients and their primary care team consider safer alternatives to sulfonylurea pills for type 2 diabetes. It may help reduce risks from sulfonylureas by improving how treatment changes are discussed and supported in routine care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years old or older
- You have type 2 diabetes (diagnosed on or before 12/31/2021)
- You currently take a sulfonylurea diabetes medicine (or medicines)
- You have seen a University Hospitals (UH) primary care doctor at least 2 times since 2021
- You do not have type 1 diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what happens when people with type 2 diabetes switch from a short course of intensive insulin therapy to different daily diabetes medicines. It aims to find which option helps keep blood sugar under control and might be easier for you.
This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.
This study tests a program that helps people with type 2 diabetes make treatment decisions together with their doctors. The goal is to improve how care decisions are made, potentially leading to better health outcomes.
This study tests a way to help older adults with type 2 diabetes who use insulin avoid dangerously low blood sugar. You would use a continuous glucose monitor and get support via email or internet to stay safe.
This trial tests a new medicine, UBT251, to see how well it lowers blood sugar in people with type 2 diabetes. It compares different doses to find the best one for you.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
Hear when a new Type2diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.